Sionna Therapeutics, Inc. (SION)
Last updated: 2026-10-21 08:05:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Sionna Therapeutics, Inc. (SION) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.15, with a market capitalization of $181.30M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.78 to $54.97. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$181.30M | |
$4.15 | |
$54.97 | |
$3.78 | |
$4.15 | |
79.00 | |
2.26M | |
-- | |
$54.97 | |
$3.78 | |
-- | |
-- |
Sionna Therapeutics, Inc. (SION) Pre-Market Stock Price
Sionna Therapeutics, Inc. (SION) is trading at $4.15 in pre-market trading as of 2026-10-21 08:02:00, unchanged from the previous close of $4.15
Pre-market trading shows how investors are pricing SION before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.
Sionna Therapeutics, Inc. (SION) 7-Day Stock Price Change
Over the past seven days, Sionna Therapeutics, Inc. (SION) moved from $4.69 to $4.15, representing a decline of 11.51% ($0.54).
The stock traded between $3.78 and $4.93 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.09 million shares, up versus the previous seven-day period, indicating higher trading activity.
SION 52-Week Price Position
Position in Range: 0.7%
SION is currently trading at $4.15, placing it 0.7% of the way from its 52-week low of $3.78 to its 52-week high of $54.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Sionna Therapeutics, Inc. (SION)?
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
Sionna Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 59 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Sionna Therapeutics, Inc. (SION) Stock on MEXC
Eligible investors can buy real shares of Sionna Therapeutics, Inc. (SION) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Sionna Therapeutics, Inc. (SION) stock price today?
2.Is SION stock going up or down today?
3.What is SION pre-market price?
4.What is SION after-hours price?
5.Is SION stock trading now?
6.Where does SION sit relative to its 52-week high and low?
7.What sector is Sionna Therapeutics, Inc. in?
8.What is Sionna Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is SION valued in terms of P/E ratio and EPS?
10.Does Sionna Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SION Stock Calculator
Estimate the value between SION shares and USD.
SION Shares to USD
1.00 SION shares = 4.15 USD
Calculations are estimates based on the latest available price and are for reference only.


